Trajectory analysis of drug-research trends in pancreatic cancer on PubMed and ClinicalTrials.gov

Yoo Kyung Jeong, Go Eun Heo, Keun Young Kang, Dong Sup Yoon, Min Song

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Increasing interest in developing treatments for pancreatic cancer has led to a surge in publications in the field. Analyses of drug-research trends are needed to minimize risk in anti-cancer drug development. Here, we analyzed publications on anti-cancer drugs extracted from PubMed records and ClinicalTrials datasets. We conducted a drug cluster analysis by proposing the entity Dirichlet Multinomial Regression (eDMR) technique and in-depth network analysis of drug cluster and target proteins. The results show two distinct research clusters in both the ClinicalTrials dataset and the PubMed records. Specifically, various targets associated with anti-cancer drugs are investigated in new drug testing while the diverse chemicals are studied together with a standard therapeutic agent in the academic literature. In addition, our study confirms that drug research published in PubMed is preceded by clinical trials. Although we only evaluate drugs for pancreatic cancer in the present study, our method can be applied to drug-research trends of other diseases.

Original languageEnglish
Pages (from-to)273-285
Number of pages13
JournalJournal of Informetrics
Volume10
Issue number1
DOIs
Publication statusPublished - 2016 Feb 1

Fingerprint

cancer
Trajectories
drug
trend
Cluster analysis
Electric network analysis
Proteins
Testing
network analysis
cluster analysis
Disease
regression

All Science Journal Classification (ASJC) codes

  • Computer Science Applications
  • Library and Information Sciences

Cite this

Jeong, Yoo Kyung ; Heo, Go Eun ; Kang, Keun Young ; Yoon, Dong Sup ; Song, Min. / Trajectory analysis of drug-research trends in pancreatic cancer on PubMed and ClinicalTrials.gov. In: Journal of Informetrics. 2016 ; Vol. 10, No. 1. pp. 273-285.
@article{b412a210cb6245b7831b25581d896d72,
title = "Trajectory analysis of drug-research trends in pancreatic cancer on PubMed and ClinicalTrials.gov",
abstract = "Increasing interest in developing treatments for pancreatic cancer has led to a surge in publications in the field. Analyses of drug-research trends are needed to minimize risk in anti-cancer drug development. Here, we analyzed publications on anti-cancer drugs extracted from PubMed records and ClinicalTrials datasets. We conducted a drug cluster analysis by proposing the entity Dirichlet Multinomial Regression (eDMR) technique and in-depth network analysis of drug cluster and target proteins. The results show two distinct research clusters in both the ClinicalTrials dataset and the PubMed records. Specifically, various targets associated with anti-cancer drugs are investigated in new drug testing while the diverse chemicals are studied together with a standard therapeutic agent in the academic literature. In addition, our study confirms that drug research published in PubMed is preceded by clinical trials. Although we only evaluate drugs for pancreatic cancer in the present study, our method can be applied to drug-research trends of other diseases.",
author = "Jeong, {Yoo Kyung} and Heo, {Go Eun} and Kang, {Keun Young} and Yoon, {Dong Sup} and Min Song",
year = "2016",
month = "2",
day = "1",
doi = "10.1016/j.joi.2016.01.003",
language = "English",
volume = "10",
pages = "273--285",
journal = "Journal of Informetrics",
issn = "1751-1577",
publisher = "Elsevier BV",
number = "1",

}

Trajectory analysis of drug-research trends in pancreatic cancer on PubMed and ClinicalTrials.gov. / Jeong, Yoo Kyung; Heo, Go Eun; Kang, Keun Young; Yoon, Dong Sup; Song, Min.

In: Journal of Informetrics, Vol. 10, No. 1, 01.02.2016, p. 273-285.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Trajectory analysis of drug-research trends in pancreatic cancer on PubMed and ClinicalTrials.gov

AU - Jeong, Yoo Kyung

AU - Heo, Go Eun

AU - Kang, Keun Young

AU - Yoon, Dong Sup

AU - Song, Min

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Increasing interest in developing treatments for pancreatic cancer has led to a surge in publications in the field. Analyses of drug-research trends are needed to minimize risk in anti-cancer drug development. Here, we analyzed publications on anti-cancer drugs extracted from PubMed records and ClinicalTrials datasets. We conducted a drug cluster analysis by proposing the entity Dirichlet Multinomial Regression (eDMR) technique and in-depth network analysis of drug cluster and target proteins. The results show two distinct research clusters in both the ClinicalTrials dataset and the PubMed records. Specifically, various targets associated with anti-cancer drugs are investigated in new drug testing while the diverse chemicals are studied together with a standard therapeutic agent in the academic literature. In addition, our study confirms that drug research published in PubMed is preceded by clinical trials. Although we only evaluate drugs for pancreatic cancer in the present study, our method can be applied to drug-research trends of other diseases.

AB - Increasing interest in developing treatments for pancreatic cancer has led to a surge in publications in the field. Analyses of drug-research trends are needed to minimize risk in anti-cancer drug development. Here, we analyzed publications on anti-cancer drugs extracted from PubMed records and ClinicalTrials datasets. We conducted a drug cluster analysis by proposing the entity Dirichlet Multinomial Regression (eDMR) technique and in-depth network analysis of drug cluster and target proteins. The results show two distinct research clusters in both the ClinicalTrials dataset and the PubMed records. Specifically, various targets associated with anti-cancer drugs are investigated in new drug testing while the diverse chemicals are studied together with a standard therapeutic agent in the academic literature. In addition, our study confirms that drug research published in PubMed is preceded by clinical trials. Although we only evaluate drugs for pancreatic cancer in the present study, our method can be applied to drug-research trends of other diseases.

UR - http://www.scopus.com/inward/record.url?scp=84957605976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957605976&partnerID=8YFLogxK

U2 - 10.1016/j.joi.2016.01.003

DO - 10.1016/j.joi.2016.01.003

M3 - Article

VL - 10

SP - 273

EP - 285

JO - Journal of Informetrics

JF - Journal of Informetrics

SN - 1751-1577

IS - 1

ER -